Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ana Gleisner

Concepts (344)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatectomy
58
2026
273
8.370
 Why?
Liver Neoplasms
53
2026
783
6.930
 Why?
Carcinoma, Hepatocellular
37
2026
372
6.300
 Why?
Pancreatic Neoplasms
25
2025
927
3.870
 Why?
Cholangiocarcinoma
18
2026
106
3.630
 Why?
Adenocarcinoma
25
2024
931
3.320
 Why?
Bile Duct Neoplasms
17
2026
128
3.310
 Why?
Laparoscopy
10
2026
475
3.040
 Why?
Neoplasm Recurrence, Local
26
2026
1141
2.790
 Why?
Sentinel Lymph Node
8
2022
49
2.650
 Why?
Minimally Invasive Surgical Procedures
8
2026
192
2.430
 Why?
Melanoma
12
2022
761
2.390
 Why?
Sentinel Lymph Node Biopsy
12
2025
118
2.320
 Why?
Skin Neoplasms
12
2022
847
2.290
 Why?
Pancreaticoduodenectomy
11
2024
135
2.150
 Why?
Postoperative Complications
26
2026
2920
1.990
 Why?
Lymph Node Excision
12
2025
173
1.990
 Why?
Pancreatectomy
8
2025
285
1.750
 Why?
Tumor Burden
17
2026
322
1.730
 Why?
Robotic Surgical Procedures
4
2026
182
1.540
 Why?
Survival Rate
40
2026
2092
1.480
 Why?
Retrospective Studies
96
2026
17101
1.460
 Why?
Prognosis
48
2026
4293
1.330
 Why?
Aged
97
2026
25947
1.300
 Why?
Lymph Nodes
10
2026
502
1.280
 Why?
Colorectal Neoplasms
10
2026
848
1.240
 Why?
Bilirubin
6
2025
97
1.140
 Why?
Databases, Factual
20
2025
1486
1.100
 Why?
Middle Aged
105
2026
35928
1.100
 Why?
Breast Neoplasms
6
2025
2456
1.100
 Why?
Lymphatic Metastasis
16
2026
334
0.990
 Why?
Liver Transplantation
12
2025
823
0.960
 Why?
Esophageal Neoplasms
8
2025
349
0.940
 Why?
Esophagectomy
4
2021
135
0.860
 Why?
Risk Assessment
22
2026
3676
0.860
 Why?
Female
117
2026
78376
0.850
 Why?
Humans
148
2026
144957
0.840
 Why?
Male
112
2026
72406
0.810
 Why?
Serum Albumin
6
2025
147
0.790
 Why?
Conversion to Open Surgery
2
2020
22
0.780
 Why?
Thrombelastography
1
2024
178
0.770
 Why?
Neoplasm Staging
14
2026
1465
0.760
 Why?
alpha-Fetoproteins
5
2025
40
0.760
 Why?
Nomograms
2
2022
59
0.750
 Why?
Follow-Up Studies
25
2025
5417
0.700
 Why?
Carcinoma, Pancreatic Ductal
5
2023
292
0.690
 Why?
Rectal Neoplasms
5
2023
158
0.670
 Why?
Machine Learning
4
2026
587
0.580
 Why?
Colonic Neoplasms
3
2024
260
0.570
 Why?
Treatment Outcome
30
2026
11695
0.540
 Why?
Head and Neck Neoplasms
6
2019
562
0.510
 Why?
Quality of Life
2
2019
3192
0.500
 Why?
Metastasectomy
3
2024
19
0.500
 Why?
CA-19-9 Antigen
3
2026
34
0.490
 Why?
Peritoneal Neoplasms
3
2024
103
0.470
 Why?
Neoadjuvant Therapy
11
2023
463
0.460
 Why?
Colectomy
3
2013
107
0.460
 Why?
Hepatic Artery
2
2026
53
0.460
 Why?
Aged, 80 and over
20
2025
8279
0.440
 Why?
Predictive Value of Tests
9
2025
2118
0.440
 Why?
Liver Failure
3
2009
83
0.430
 Why?
Disease-Free Survival
11
2025
769
0.390
 Why?
Axilla
3
2023
51
0.390
 Why?
Length of Stay
8
2026
1337
0.390
 Why?
Stomach Neoplasms
2
2024
128
0.380
 Why?
Risk Factors
20
2025
10792
0.380
 Why?
Blood Loss, Surgical
4
2026
112
0.370
 Why?
Cytoreduction Surgical Procedures
3
2024
67
0.370
 Why?
Decision Making
1
2019
980
0.360
 Why?
Propensity Score
4
2024
367
0.350
 Why?
Ampulla of Vater
2
2024
39
0.330
 Why?
Margins of Excision
5
2025
51
0.330
 Why?
Decision Support Techniques
2
2025
456
0.320
 Why?
Adult
39
2026
40506
0.310
 Why?
ROC Curve
5
2025
615
0.310
 Why?
United States
19
2025
15988
0.310
 Why?
Benchmarking
2
2021
188
0.290
 Why?
Liver Cirrhosis
5
2025
288
0.290
 Why?
Preoperative Care
5
2025
380
0.290
 Why?
Single Photon Emission Computed Tomography Computed Tomography
2
2019
15
0.290
 Why?
Serum Albumin, Human
2
2025
7
0.290
 Why?
Neuroendocrine Tumors
2
2023
114
0.290
 Why?
Gallbladder Neoplasms
2
2024
20
0.280
 Why?
Time Factors
10
2025
7183
0.270
 Why?
Quality Indicators, Health Care
3
2026
335
0.260
 Why?
Mastectomy, Segmental
2
2017
108
0.250
 Why?
Lymphocytes
2
2025
382
0.240
 Why?
Proportional Hazards Models
5
2025
1325
0.240
 Why?
Inflammation
4
2025
2880
0.240
 Why?
Survival Analysis
7
2024
1385
0.230
 Why?
Time-to-Treatment
2
2025
245
0.230
 Why?
Catheter Ablation
2
2008
353
0.230
 Why?
Abdominal Neoplasms
1
2025
47
0.230
 Why?
Vena Cava, Inferior
1
2026
81
0.230
 Why?
Infusions, Intra-Arterial
1
2025
61
0.220
 Why?
Hyperglycemia
2
2020
375
0.220
 Why?
gamma-Glutamyltransferase
1
2025
42
0.220
 Why?
Neoplasm Invasiveness
6
2026
509
0.220
 Why?
Portal Vein
1
2026
114
0.220
 Why?
Medical Futility
1
2025
31
0.220
 Why?
Anastomotic Leak
1
2024
44
0.220
 Why?
Abdomen, Acute
1
2004
21
0.210
 Why?
Age Factors
5
2025
3335
0.210
 Why?
Cohort Studies
10
2023
5965
0.200
 Why?
Bacterial Infections
3
2006
246
0.200
 Why?
End Stage Liver Disease
1
2025
94
0.200
 Why?
Lymphopenia
1
2024
65
0.200
 Why?
Biomarkers, Tumor
3
2025
1322
0.200
 Why?
Chemotherapy, Adjuvant
6
2025
421
0.200
 Why?
Operative Time
4
2026
175
0.200
 Why?
Odds Ratio
4
2019
1077
0.200
 Why?
Combined Modality Therapy
6
2024
1268
0.200
 Why?
Cannabinoids
1
2025
182
0.190
 Why?
Kaplan-Meier Estimate
4
2025
966
0.190
 Why?
Practice Guidelines as Topic
2
2024
1563
0.190
 Why?
Multilocus Sequence Typing
1
2022
17
0.190
 Why?
C-Reactive Protein
1
2025
417
0.190
 Why?
SEER Program
2
2014
224
0.190
 Why?
Lymphoscintigraphy
2
2019
9
0.190
 Why?
Sunburn
1
2002
26
0.190
 Why?
Surgical Oncology
1
2022
30
0.180
 Why?
Sunscreening Agents
1
2002
25
0.180
 Why?
Patient Selection
2
2025
719
0.180
 Why?
Nevus, Pigmented
1
2002
35
0.180
 Why?
Pelvic Exenteration
2
2019
12
0.180
 Why?
Lung Neoplasms
3
2023
2642
0.180
 Why?
Mastectomy
1
2023
162
0.180
 Why?
Prospective Studies
9
2025
7997
0.180
 Why?
Killer Cells, Natural
1
2025
469
0.180
 Why?
Klatskin Tumor
1
2021
18
0.180
 Why?
Anesthetics, Inhalation
1
2021
52
0.160
 Why?
Chemoradiotherapy
4
2023
239
0.160
 Why?
Body Mass Index
3
2025
2438
0.160
 Why?
Propofol
1
2021
85
0.160
 Why?
Hyperthermia, Induced
2
2020
121
0.160
 Why?
Organ Preservation
4
2023
130
0.160
 Why?
Cancer Survivors
1
2025
327
0.160
 Why?
Scalp
1
2019
37
0.150
 Why?
Artificial Intelligence
1
2024
367
0.150
 Why?
Regression Analysis
2
2019
1003
0.150
 Why?
Reoperation
3
2017
631
0.140
 Why?
Pancreatic Diseases
1
2019
66
0.140
 Why?
Registries
2
2021
2385
0.140
 Why?
Skin Pigmentation
1
2019
48
0.140
 Why?
Neutrophils
1
2024
1134
0.140
 Why?
Phenotype
2
2026
3164
0.140
 Why?
Referral and Consultation
1
2024
853
0.130
 Why?
Appendiceal Neoplasms
1
2017
28
0.130
 Why?
Tomography, X-Ray Computed
3
2025
2738
0.130
 Why?
Population Surveillance
1
2021
485
0.130
 Why?
Anesthesia
1
2021
258
0.130
 Why?
Common Bile Duct Neoplasms
1
2017
27
0.130
 Why?
Patient Acceptance of Health Care
1
2024
886
0.130
 Why?
Patient Compliance
1
2021
589
0.130
 Why?
Pylorus
1
2017
17
0.130
 Why?
Gastric Outlet Obstruction
1
2017
12
0.130
 Why?
Carcinoma, Ductal, Breast
1
2017
88
0.130
 Why?
Waiting Lists
2
2009
263
0.130
 Why?
Carcinoma, Renal Cell
2
2026
234
0.130
 Why?
Disease Management
1
2021
647
0.120
 Why?
Radiotherapy, Intensity-Modulated
1
2018
142
0.120
 Why?
Analgesics, Opioid
1
2025
1143
0.120
 Why?
Hospitals, High-Volume
1
2016
49
0.120
 Why?
Nutritional Status
1
2019
354
0.120
 Why?
Cancer Care Facilities
1
2016
48
0.120
 Why?
Neoplasms
2
2022
2884
0.120
 Why?
Neuromuscular Agents
1
2017
45
0.120
 Why?
Hospitals
1
2021
732
0.120
 Why?
Botulinum Toxins, Type A
1
2017
58
0.120
 Why?
Obesity
2
2025
3082
0.120
 Why?
Genital Neoplasms, Female
1
2017
99
0.120
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1958
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2016
104
0.120
 Why?
Cannabis
1
2023
509
0.120
 Why?
Patient Reported Outcome Measures
1
2019
489
0.110
 Why?
Platelet Count
2
2025
96
0.110
 Why?
Adenoma
1
2017
218
0.110
 Why?
Kidney Neoplasms
2
2026
412
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
1182
0.110
 Why?
Delivery of Health Care
1
2021
947
0.100
 Why?
Radiosurgery
1
2018
401
0.100
 Why?
Patient Readmission
1
2019
759
0.100
 Why?
Antineoplastic Agents
3
2021
2197
0.100
 Why?
Morbidity
4
2021
323
0.100
 Why?
Unnecessary Procedures
1
2014
54
0.100
 Why?
Hospital Mortality
4
2024
1031
0.100
 Why?
Trauma Centers
2
2014
462
0.100
 Why?
Anti-Bacterial Agents
1
2004
1915
0.100
 Why?
Abdomen
1
2013
141
0.090
 Why?
Radiation Dosage
1
2014
193
0.090
 Why?
Preoperative Period
2
2025
149
0.090
 Why?
Renal Insufficiency
1
2013
169
0.090
 Why?
Pandemics
3
2025
1695
0.080
 Why?
Clinical Competence
1
2019
1244
0.080
 Why?
Severity of Illness Index
3
2025
2925
0.080
 Why?
Asia
2
2021
70
0.080
 Why?
Triage
1
2012
249
0.080
 Why?
Logistic Models
2
2025
2119
0.080
 Why?
Europe
2
2021
412
0.080
 Why?
Organ Preservation Solutions
2
2006
47
0.070
 Why?
Kidney Transplantation
2
2013
704
0.070
 Why?
Graft Survival
2
2009
526
0.070
 Why?
Diagnostic Tests, Routine
2
2024
108
0.070
 Why?
Brain Injuries
1
2014
508
0.070
 Why?
Practice Patterns, Physicians'
1
2017
1358
0.070
 Why?
Bile Ducts, Extrahepatic
1
2008
20
0.070
 Why?
Laparotomy
1
2008
112
0.070
 Why?
Biliary Tract Surgical Procedures
1
2008
28
0.070
 Why?
Case-Control Studies
2
2007
3608
0.070
 Why?
Cholangitis, Sclerosing
1
2008
60
0.060
 Why?
Electrocoagulation
1
2007
36
0.060
 Why?
Anus Neoplasms
1
2007
32
0.060
 Why?
Intraoperative Care
1
2007
62
0.060
 Why?
Congenital Hypothyroidism
1
1986
10
0.060
 Why?
Brazil
2
2008
180
0.060
 Why?
Multivariate Analysis
2
2025
1540
0.060
 Why?
Young Adult
7
2022
14126
0.060
 Why?
Guideline Adherence
2
2024
589
0.060
 Why?
Retroperitoneal Neoplasms
1
2026
28
0.060
 Why?
Vascular Patency
1
2026
121
0.060
 Why?
Fluorouracil
2
2022
235
0.060
 Why?
Ultrasonography, Interventional
1
2007
160
0.060
 Why?
Mycophenolic Acid
1
2006
120
0.060
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
29
0.050
 Why?
Sample Size
1
2025
123
0.050
 Why?
Lymphocyte Count
1
2024
164
0.050
 Why?
Adolescent
9
2022
22453
0.050
 Why?
Wounds and Injuries
1
2012
957
0.050
 Why?
Zygomycosis
1
2003
6
0.050
 Why?
Radiotherapy, Adjuvant
2
2019
222
0.050
 Why?
Bile Ducts, Intrahepatic
1
2024
63
0.050
 Why?
Sarcoma
1
2026
205
0.050
 Why?
Developmental Disabilities
1
1986
281
0.050
 Why?
Cross-Sectional Studies
3
2026
5872
0.050
 Why?
Cluster Analysis
1
2025
521
0.050
 Why?
Comorbidity
2
2022
1660
0.050
 Why?
Hepatocytes
1
2004
224
0.050
 Why?
Antibiotic Prophylaxis
1
2004
129
0.050
 Why?
Gastrectomy
1
2024
161
0.050
 Why?
Biology
1
2023
91
0.050
 Why?
Capecitabine
1
2022
57
0.050
 Why?
Appendicitis
1
2004
148
0.050
 Why?
Carcinoma, Squamous Cell
1
2007
642
0.040
 Why?
Pneumonectomy
1
2023
169
0.040
 Why?
Anesthesia, Intravenous
1
2021
24
0.040
 Why?
Anesthetics, Intravenous
1
2021
69
0.040
 Why?
Esophagogastric Junction
1
2021
56
0.040
 Why?
Surgical Wound Infection
1
2004
316
0.040
 Why?
Induction Chemotherapy
1
2021
87
0.040
 Why?
Models, Biological
1
2008
1822
0.040
 Why?
Thoracoscopy
1
2020
62
0.040
 Why?
Liver
2
2006
1888
0.040
 Why?
Image-Guided Biopsy
1
2019
41
0.040
 Why?
Medical Oncology
1
2022
332
0.040
 Why?
Adenocarcinoma, Mucinous
1
2020
76
0.040
 Why?
Societies, Medical
1
2024
887
0.040
 Why?
Perioperative Period
1
2017
71
0.030
 Why?
Oxidative Stress
1
2004
1339
0.030
 Why?
Reproducibility of Results
1
2025
3415
0.030
 Why?
Occipital Bone
1
2017
18
0.030
 Why?
Parotid Gland
1
2017
17
0.030
 Why?
Carcinoma, Lobular
1
2017
56
0.030
 Why?
Gastric Emptying
1
2017
36
0.030
 Why?
Health Behavior
1
2002
786
0.030
 Why?
Neck
1
2017
108
0.030
 Why?
Longitudinal Studies
1
2024
2947
0.030
 Why?
Sex Factors
1
2022
2114
0.030
 Why?
Raffinose
2
2006
29
0.030
 Why?
Perioperative Care
1
2018
231
0.030
 Why?
Allopurinol
2
2006
70
0.030
 Why?
Consensus
1
2017
489
0.030
 Why?
Glucose
1
2020
1049
0.030
 Why?
Drug Administration Schedule
1
2015
783
0.020
 Why?
Adenosine
2
2006
255
0.020
 Why?
Glutathione
2
2006
375
0.020
 Why?
Glasgow Coma Scale
1
2014
213
0.020
 Why?
Vital Signs
1
2012
48
0.020
 Why?
New South Wales
1
2012
21
0.020
 Why?
Radiation Injuries
1
2014
151
0.020
 Why?
Incidence
1
2019
2883
0.020
 Why?
Baltimore
1
2012
71
0.020
 Why?
Magnetic Resonance Imaging
1
2025
3869
0.020
 Why?
Italy
1
2012
114
0.020
 Why?
Disease Progression
1
2020
2852
0.020
 Why?
Child
6
2014
22657
0.020
 Why?
Hospital Costs
1
2012
124
0.020
 Why?
Pharmaceutical Preparations
1
2013
170
0.020
 Why?
Biological Therapy
1
2011
28
0.020
 Why?
Child, Preschool
4
2014
11799
0.020
 Why?
Albuminuria
1
1992
190
0.020
 Why?
Chi-Square Distribution
1
2012
529
0.020
 Why?
Injury Severity Score
1
2012
600
0.020
 Why?
Lung
1
2023
4109
0.020
 Why?
Glomerular Filtration Rate
1
2013
760
0.020
 Why?
Surveys and Questionnaires
1
2022
6053
0.020
 Why?
Carcinoembryonic Antigen
1
2008
39
0.020
 Why?
Infant, Newborn
2
2014
6434
0.020
 Why?
Immunosuppressive Agents
1
2013
847
0.020
 Why?
Antimetabolites, Antineoplastic
1
2008
105
0.020
 Why?
Radiopharmaceuticals
1
2008
207
0.020
 Why?
Sensitivity and Specificity
1
2012
1990
0.020
 Why?
Fluorodeoxyglucose F18
1
2008
162
0.020
 Why?
Infant
3
2014
10039
0.020
 Why?
Retreatment
1
2007
77
0.020
 Why?
Cholecystectomy
1
2007
59
0.020
 Why?
Colorado
1
2017
4564
0.020
 Why?
Incidental Findings
1
2007
80
0.020
 Why?
Positron-Emission Tomography
1
2008
343
0.020
 Why?
Neoplasm, Residual
1
2007
139
0.020
 Why?
Biopsy, Needle
1
2007
183
0.020
 Why?
Tablets, Enteric-Coated
1
2006
5
0.020
 Why?
Hepatitis B
1
2007
66
0.020
 Why?
Histidine
1
2006
66
0.020
 Why?
Radiography
1
2008
845
0.010
 Why?
Psychological Tests
1
1986
132
0.010
 Why?
Graft Rejection
1
2009
540
0.010
 Why?
Overweight
1
2010
609
0.010
 Why?
Tryptophan
1
2006
181
0.010
 Why?
Glutathione Disulfide
1
2004
32
0.010
 Why?
Insulin
2
2006
2507
0.010
 Why?
Hepatitis C
1
2007
254
0.010
 Why?
Sulfamethoxypyridazine
1
1983
1
0.010
 Why?
Trimethoprim
1
1983
7
0.010
 Why?
Liver Function Tests
1
2004
106
0.010
 Why?
Gastrointestinal Diseases
1
2006
216
0.010
 Why?
Anti-Infective Agents, Urinary
1
1983
16
0.010
 Why?
Amphotericin B
1
2003
37
0.010
 Why?
Liver Diseases
1
2006
304
0.010
 Why?
Antifungal Agents
1
2003
149
0.010
 Why?
Immunocompromised Host
1
2003
201
0.010
 Why?
Cause of Death
1
2004
472
0.010
 Why?
Urinary Tract Infections
1
1983
203
0.010
 Why?
Reperfusion Injury
1
2004
300
0.010
 Why?
Cardiovascular Diseases
1
1992
2171
0.010
 Why?
Diabetes Mellitus, Type 1
1
1992
3890
0.010
 Why?
Cholesterol
1
1992
408
0.000
 Why?
Blood Pressure
1
1992
1769
0.000
 Why?
Sulfamethoxazole
1
1983
7
0.000
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1983
42
0.000
 Why?
Escherichia coli Infections
1
1983
129
0.000
 Why?
Drug Combinations
1
1983
392
0.000
 Why?
Microbial Sensitivity Tests
1
1983
371
0.000
 Why?
Escherichia coli
1
1983
855
0.000
 Why?
Clinical Trials as Topic
1
1983
1054
0.000
 Why?
Gleisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (344) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)